Originally approved to treat diabetes, these GLP-1 agonists have since made headlines not just for their ability to manage obesity but to also positively influence a host of other conditions, from cardiovascular risk and fatty liver disease to neurogenerative diseases
These effects were observed in both in vitro and in vivo models, indicating a strong potential for SiO 2 NPs to initiate and develop PD-like symptoms (74)
Its clinical development was halted, so there is no completed pivotal trial, no approved label, no reviewed dose, and no regulatory safety determination
By pairing copper peptides for collagen with hormone optimization, nutritional support, and other regenerative options, the team focuses on both visible results and the underlying biology that drives how you age
Managing hydration on GLP-1 treatments Preventative strategies Increase fluid intake to at least 2-3 litres daily (unless contraindicated) Monitor urine colour aim for pale yellow as an indicator of good hydration Establish a regular drinking schedule rather than relying on thirst Use oral rehydration solutions if experiencing significant fluid losses Track daily fluid intake using a dedicated water bottle or app Dietary considerations Consume hydrating foods (fruits, vegetables, soups, broths) Replace electrolytes lost through vomiting or diarrhoea Limit caffeine and alcohol which can worsen dehydration Consider small, frequent sips if nausea makes drinking difficult Include foods with high water content like cucumber, watermelon, and celery Monitoring approaches Weigh yourself regularly rapid weight loss may indicate fluid loss Check for skin turgor by pinching skin on the back of hand
This often affects the abdominal area, hips, or thighs
